Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 35,431 |
|
|||||
| News | (1) | ||||||
| Day High | 0.5298 | Low High |
|||||
| Day Low | 0.458 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Orgenesis Inc | ORGS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0289 | 5.95% | 0.5149 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.458 | 0.458 | 0.5298 | 0.5149 | 0.486 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 85 | 35,431 | US$ 0.4817466 | US$ 17,069 | - | 0.25 - 1.50 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:05:43 | 10 | US$ 0.5247 | USD |
Orgenesis Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 15.94M | 31.88M | - | 530k | -55.36M | -1.74 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Orgenesis News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ORGS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.497 | 0.5298 | 0.45 | 0.4813934 | 18,015 | 0.0179 | 3.60% |
| 1 Month | 0.547 | 0.6349 | 0.45 | 0.5277707 | 36,303 | -0.0321 | -5.87% |
| 3 Months | 0.82 | 0.913 | 0.3044 | 0.5348579 | 171,975 | -0.3051 | -37.21% |
| 6 Months | 0.44 | 0.913 | 0.25 | 0.5012162 | 160,148 | 0.0749 | 17.02% |
| 1 Year | 1.24 | 1.50 | 0.25 | 0.5766374 | 116,757 | -0.7251 | -58.48% |
| 3 Years | 4.89 | 5.85 | 0.25 | 1.90 | 85,604 | -4.38 | -89.47% |
| 5 Years | 4.30 | 12.00 | 0.25 | 3.70 | 100,541 | -3.79 | -88.03% |
Orgenesis Description
| Orgenesis Inc is a global biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). Its geographical segments include Korea, United Arab Emirates, China, India, and Greece. |
